Copyright
©The Author(s) 2024.
World J Gastrointest Surg. Jun 27, 2024; 16(6): 1709-1716
Published online Jun 27, 2024. doi: 10.4240/wjgs.v16.i6.1709
Published online Jun 27, 2024. doi: 10.4240/wjgs.v16.i6.1709
Table 3 Comparison of adverse reactions between the two groups
| Index | Study group (n = 45) | Control group (n = 45) | χ2 | P value | ||
| n | % | n | % | |||
| Abnormal liver function | 1 | 2.22 | 5 | 11.11 | ||
| Nausea and vomiting | 3 | 6.67 | 6 | 13.33 | ||
| Diarrhoea | 2 | 4.44 | 3 | 6.67 | ||
| Decreased white blood cells | 1 | 2.22 | 2 | 4.44 | ||
| Total | 7 | 15.56 | 16 | 35.56 | 10.512 | < 0.001 |
- Citation: Wang T, Zhang LY. Evaluation of oxaliplatin and tigio combination therapy in locally advanced gastric cancer. World J Gastrointest Surg 2024; 16(6): 1709-1716
- URL: https://www.wjgnet.com/1948-9366/full/v16/i6/1709.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v16.i6.1709